An analysis of the Chief Electoral Officer, Tamil Nadu’s polling station-level list of over 97 lakh deleted electors in Tamil Nadu reveals several anomalies that require closer examination. The ...

Around 9.7 million names might be dropped from the electoral rolls of Tamil Nadu after the special intensive revision, data from the election commission showed on Friday, marking the highest ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Fifty Tamil tutors are assiduously trying to impart the basics of the language to about 1,500 Hindi-speaking students at various schools under the Tamil Karkalam (Let’s Learn Tamil) programme, ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...

Dec 8 (Reuters) - Recursion Pharma, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in ...

PALAKKAD: As Kerala enters the final phase of preparations for the local body elections, a deep sense of unease is growing among Tamil-speaking minority communities – particularly in Palakkad – over ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

The fourth edition of the Kashi Tamil Sangamam will be organised from Tuesday (December 2), with a theme 'Let Us Learn Tamil – Tamil Karkalam' in Varanasi, Uttar Pradesh. The Sangamam will begin from ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...